BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3761576)

  • 1. [Stomatocytosis with hemolysis presumably induced by vincristine administration in a patient with non-Hodgkin's lymphoma].
    Ohsaka A; Tsuboyama A; Yoshida M; Kano Y; Sakamoto S; Miura Y; Shimoda M; Hashimoto M; Kanzaki A; Yawata Y
    Rinsho Ketsueki; 1986 Jun; 27(6):891-7. PubMed ID: 3761576
    [No Abstract]   [Full Text] [Related]  

  • 2. A transient hemolytic reaction and stomatocytosis following vinca alkaloid administration.
    Ohsaka A; Kano Y; Sakamoto S; Kanzaki A; Hashimoto M; Yawata Y; Miura Y
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):7-17. PubMed ID: 2741652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
    Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
    Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
    [No Abstract]   [Full Text] [Related]  

  • 4. Ataxia and athetosis as side effects of chemotherapy with vincristine in non-Hodgkin's lymphoma.
    Carpentieri U; Lockhart LH
    Cancer Treat Rep; 1978 Apr; 62(4):561-2. PubMed ID: 657152
    [No Abstract]   [Full Text] [Related]  

  • 5. [Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)].
    Sakano T
    Rinsho Ketsueki; 1981 Feb; 22(2):159-77. PubMed ID: 7031290
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-Hodgkin's lymphoma in children. Study of 30 patients at the Caracas University Hospital].
    Acquatella G; Urdaneta N; Rosas Uribe A; García Guevara R
    Sangre (Barc); 1985; 30(3):253-83. PubMed ID: 3839940
    [No Abstract]   [Full Text] [Related]  

  • 7. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME; Laber DA
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A preliminary study of vincristine, methotrexate, and prednisolone (VM*P) combination chemotherapy for advanced adult non-Hodgkin's lymphoma].
    Takenaka T; Shimoyama M; Minato K; Kitahara T; Konda C
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1814-20. PubMed ID: 7184375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy for localized non-Hodgkin's lymphoma with CVP therapy].
    Horikoshi N; Inagaki J; Ogawa M
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1878-84. PubMed ID: 6683953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in adult non-Hodgkin's lymphoma. Current concepts of classification, diagnosis, and management.
    Rassiga AL
    Arch Intern Med; 1980 Dec; 140(12):1647-51. PubMed ID: 6161589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
    Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need of adequate staging and aggressive therapy in non-Hodgkin's lymphomas. Report of 66 cases.
    Johansson RT; Joensuu H
    Strahlentherapie; 1983 Feb; 159(2):104-8. PubMed ID: 6836627
    [No Abstract]   [Full Text] [Related]  

  • 15. Hexachloroparaxylol induced hemolysis.
    Liu J; Xueyung Y; Wengan T; Jitao T
    Chin Med J (Engl); 1979 Apr; 92(4):286-91. PubMed ID: 108063
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myocardial infarction induced by vincristine in patients with Hodgkin's lymphoma. Description of 2 cases and review of the literature].
    Barra M; Brignole M; Sartore B; Bertulla A
    G Ital Cardiol; 1985 Jan; 15(1):107-11. PubMed ID: 4007346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte membrane defects in hemolytic anemias found through derivative thermal analysis of electric impedance.
    Ivanov IT; Tolekova A; Chakaarova P
    J Biochem Biophys Methods; 2007 Jun; 70(4):641-8. PubMed ID: 17395266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of modified LSA2L2 therapy in children with non-Hodgkin's lymphoma].
    Shitara T; Kuribayashi T; Oshima Y; Suetake N; Hiraishi Y
    Rinsho Ketsueki; 1984 Oct; 25(10):1594-9. PubMed ID: 6549186
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
    Uno S; Katayama K; Dobashi N; Hirano A; Ogihara A; Yamazaki H; Usui N; Kobayashi T; Inoue K; Kuraishi Y
    Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy of a quadruple combination chemotherapy with ACNU, adriamycin, methotrexate, and prednisolone for patients with non-Hodgkin's lymphoma, who were refractory to VEPA (P) treatment].
    Niitsu H; Fukuda M; Fukuda S; Takatsu H; Nakayama Y; Hirokawa M; Mamiya S; Miura I; Takahashi F; Yoshida K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2585-9. PubMed ID: 6594975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.